当前位置：首页 > 文献互助 > 互助详情

补充材料Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with phenotypic metabolic dysfunction-associated steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial复制

用户52cCOvPGTD8g 6小时前 13 待确认帖子自动结束时间: 2025-06-22 09:57:51

1. 请及时下载文件确认是否正确, 系统将在 2025-06-24 11:03:36 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

文献链接:复制

其他信息:

互助时间线

jodie0105上传了文件(zip 889.46 KB), 求助状态变成待确认

Influence of Interfacial Oxides at TCO/Doped Si Thin Film Contacts on the Charge Carrier Transport of Passivating Contacts 51分钟前

Searching molecular biomarkers correlating with BSID-III at 24 months in infants with neonatal hypoxic-ischemic encephalopathy 1小时前

Effects of a Province-Wide Change in Gestational Diabetes Mellitus Screening Policy on Treatment and Newborn Birth Weight 1小时前

VTE Prophylaxis in Critically Ill Adults 1小时前

Discovery of the Clinical Candidate YY2201 as a Highly Potent and Selective ATR Inhibitor 1小时前

Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis 2小时前

Consensus Recommendations for the Reconstitution and Aesthetic Use of Poly-D,L-Lactic Acid Microspheres 2小时前

Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments 2小时前